What Happens When Insurance Stops Covering a Medication: Next Steps

What happens when your insurer stops covering a medication?
You suddenly face three things: a huge out-of-pocket bill, the risk of missing doses, and a paperwork fight that can take weeks.
A drug that was a $10 copay can leap to $1,500 or more a month.
This post shows exact steps for the first 24 to 72 hours, real cost examples, how appeals and exceptions work, and what to ask your doctor and insurer so you don’t get burned.

Immediate Actions When Insurance Stops Covering a Medication

When coverage stops, three things happen at once: you’re staring at a massive out-of-pocket bill, you might miss doses if you can’t afford to pay, and your doctor and insurer start playing phone tag over approval rules. Financially, a drug that cost $10 or $30 as a copay can suddenly jump to $200, $1,500, even north of $5,000 for a single month depending on whether it’s generic, branded, or specialty. Clinically, going without the medication for even a few days can destabilize chronic conditions, trigger relapses, or land you in the emergency room. On the administrative side, the insurer has usually changed the formulary, let a prior authorization expire, or applied a new step-therapy rule that says you need to try a cheaper drug first before they’ll pay for your current one.

The cause matters because it tells you which fix works fastest. If your prior authorization expired, your prescriber can often resubmit it within 24 to 48 hours and get a decision in three to seven business days (or 24 to 72 hours if marked urgent). If the insurer moved the drug off the formulary entirely or bumped it to a non-covered tier, you’re looking at a formal exception request or appeal, and standard timelines stretch to about 30 days for an internal decision. Step therapy means you’ll probably need documentation showing you already tried the insurer’s preferred alternatives and they didn’t work.

Act within the first 24 to 72 hours to protect your treatment and preserve appeal rights:

• Locate the denial notice or coverage change letter. Write down the drug name, effective date, and the reason code or explanation the insurer gives (formulary removal, PA denial, step therapy, quantity limit).
• Call your insurance company’s member services line. Ask for the exact reason coverage stopped, whether an expedited review is available, and the deadline to file an appeal or exception request (usually 30 to 60 days from the denial date).
• Contact your prescribing clinician the same day if possible. Request that they submit or renew a prior authorization immediately, provide a letter of medical necessity, or write a short-term prescription for a covered alternative to bridge you while appeals proceed.
• Ask the pharmacy for the exact cash price and any available manufacturer coupons. Get a written or printed quote for both a 30-day and 90-day supply so you can compare options.
• Request an expedited or urgent appeal if stopping the drug would cause serious harm. Expedited decisions are typically made within 24 to 72 hours when medical necessity is clear.
• Secure a temporary supply if possible. Some insurers will authorize a 7 to 30 day emergency fill while the appeal is pending. Your prescriber may also have samples or can write a smaller quantity prescription to prevent a treatment gap.
• Start a written log immediately. Record every phone call (date, time, representative name, reference number) and keep copies of all letters, emails, and faxes related to the denial and your response.

Why Insurance Stops Covering a Medication (Formulary, PA, and Policy Changes)

Insurers decide what they’ll pay for by maintaining a formulary, a tiered list of covered drugs that changes over time based on cost negotiations, clinical guidelines, and manufacturer rebates. Coverage often disappears or becomes unaffordable when the insurer removes a drug from the formulary entirely, moves it to a higher tier with much larger copays or coinsurance, or adds new restrictions like prior authorization or step therapy that you haven’t satisfied. These changes typically happen at annual formulary updates, and insurers are usually required to notify members 30 to 90 days before the new plan year starts (often January 1 for most commercial and Medicare plans), though mid-year changes can occur if a manufacturer pulls a rebate deal or new clinical data emerges.

Prior authorization rules are another common reason coverage stops mid-treatment. A PA approval might expire after six or 12 months, and if your prescriber doesn’t renew it before the deadline, the insurer stops paying. Step-therapy policies require you to try one or more lower-cost drugs first and document that they didn’t work or caused intolerable side effects. If that documentation is missing or incomplete, the insurer denies coverage for the higher-cost medication. Quantity limits, such as capping refills at 30 tablets per month when your dose requires 60, can also block access even though the drug is technically “covered.”

Pharmacy benefit managers often drive these decisions behind the scenes. PBMs negotiate rebates and discounts with drug manufacturers in exchange for favorable formulary placement, and when those contracts change, entire classes of medications can shift tiers or disappear from coverage overnight. The insurer’s clinical criteria, cost-control targets, and network pharmacy agreements all feed into formulary decisions, but the financial relationship between the PBM and the manufacturer is usually the largest factor in whether your specific drug stays accessible and affordable.

Out-of-Pocket Costs After Medication Coverage Ends

Once a drug becomes non-covered, you’re responsible for the full retail or negotiated cash price unless you can reverse the decision or find financial assistance. That shift can be brutal. A generic medication that was $5 or $10 under your plan might cost $15 to $30 at cash price, annoying but survivable. A brand-name drug that had a $50 copay can jump to $400, $900, or $2,500 per month. And specialty medications, biologics, infusions, injectables for chronic conditions, routinely run $3,000 to $15,000 or more for a single month’s supply when you’re paying out of pocket.

Cash prices vary wildly between pharmacies, even within the same chain in different ZIP codes. A 30-day supply of a common brand-name pill might cost $320 at one independent pharmacy, $480 at a big-box store two miles away, and $210 through a mail-order or warehouse club pharmacy. Discount cards and price-comparison tools can reduce those costs by 10 to 80 percent depending on the drug and the pharmacy’s contract with the card sponsor, but those discounts don’t count toward your insurance deductible or out-of-pocket maximum. Some pharmacies offer payment plans for large one-time costs, spreading a $1,200 bill across three or six months, though interest or fees may apply.

Typical monthly out-of-pocket ranges when paying cash or using discount cards:

• Generic oral medications: $4 to $30 for common chronic-disease drugs (many large chains and warehouse clubs offer $4 to $10 generics lists).
• Brand-name non-specialty drugs: $50 to $400 per month, occasionally higher for newer or single-source products.
• Specialty oral or injectable medications: $1,000 to $15,000+ per month. Biologics for autoimmune diseases, cancer therapies, and rare-disease treatments sit at the top end.
• 90-day mail-order supplies: Often 5 to 30 percent lower per-month cost than three separate 30-day retail fills, but require paying the full amount up front.
• Discount card programs: Savings typically range from 10 to 80 percent off retail. Cards are free or charge small per-use fees ($0 to $5).

Coverage Appeals and Exception Requests for Non-Covered Medications

An appeal is your formal request for the insurer to reverse a denial and cover the medication despite the formulary change, PA denial, or restriction. Most health plans are required to offer at least two levels of internal appeal, followed by an independent external review if the internal process fails. The clock starts ticking as soon as you receive the denial notice, and missing a filing deadline can close off your options permanently, so start the process within the first few days even if you’re still gathering documentation.

Internal Appeal Steps and Documentation

The first-level or standard internal appeal is handled by the insurer’s own reviewers, often nurses or pharmacists who compare your submission against the plan’s clinical criteria and formulary rules. You or your prescriber submit a written request for reconsideration along with medical records, lab results, clinic notes documenting your diagnosis and treatment history, a detailed list of prior medications tried (with dates, doses, and reasons they failed), and a letter of medical necessity from your prescriber explaining why this specific drug is clinically required and why alternatives won’t work. Include pharmacy invoices showing the cash price you’re facing and any communication logs with the insurer. Standard internal appeals are typically decided within about 30 calendar days, though some plans allow up to 60 days depending on state law and plan type.

If the situation is urgent, meaning that waiting 30 days could cause serious harm, significant worsening of your condition, or put your life at risk, request an expedited or urgent internal appeal. The insurer must make a decision much faster, commonly within 72 hours and sometimes as quickly as 24 hours for truly life-threatening cases. Your prescriber will need to certify in writing that the delay poses a serious health risk. Expedited appeals are appropriate for medications that control seizures, prevent organ rejection, manage severe psychiatric conditions, or treat acute infections or cancer.

Expedited and External Review Timelines

If the internal appeal is denied, you have the right to request an external review by an independent organization that is not employed by or contracted to your insurer. External review deadlines vary by state and plan type, but you generally must file within 30 to 60 days of receiving the final internal denial. The external reviewer looks at the same documentation plus the insurer’s denial rationale and issues a binding decision. The insurer must comply if the external reviewer sides with you. Standard external reviews typically take 45 to 60 days, though some stretch longer for complex cases, and expedited external reviews for urgent situations are often completed within 72 hours.

Many internal appeals succeed when prescribers provide targeted, well-documented clinical necessity and demonstrate that cheaper alternatives have already been tried and failed. Expect resolution in one to eight weeks for standard cases. Expedited pathways can restore coverage within days if the medical justification is strong and the risk of harm is clear.

Medication Alternatives: Generics, Therapeutic Substitutions, and Biosimilars

When coverage for your current medication ends, the fastest path back to affordable treatment is often switching to a clinically appropriate alternative that remains on the insurer’s formulary. Generic substitutes, chemically identical copies of brand-name drugs, typically cost 50 to 95 percent less and are covered at the lowest copay tier by most plans, making them the first option your prescriber will consider if one exists for your medication. If no generic exists, therapeutic substitution involves switching to a different drug in the same class (for example, moving from one statin to another, or one antidepressant to a different SSRI) that the insurer does cover. Cost reductions can range from 20 to 80 percent depending on the drugs involved and their tier placements.

Biosimilars, near-copies of biologic medications used for autoimmune diseases, cancer, and other complex conditions, offer another alternative when the original biologic becomes non-covered, though availability is still limited compared to small-molecule generics. Switching medications always carries clinical risk. The new drug may not work as well, may cause different or worse side effects, or may require dose adjustments and close monitoring during the transition. Your prescriber should provide a short-term bridge, often a 7 to 30 day supply of samples, a smaller prescription, or a temporary fill, while observing how you respond to the new medication and adjusting the treatment plan as needed.

Common alternative pathways when your medication loses coverage:

• Switch to an FDA-approved generic. Same active ingredient, same dose, dramatically lower cost. Usually the simplest swap with the least clinical risk.
• Try a therapeutic equivalent in the same drug class. Your prescriber selects a chemically different medication that treats the same condition and is covered by your plan. May require monitoring for efficacy and side effects during the first few weeks.
• Consider a biosimilar if you’re on a biologic. Not identical but highly similar to the reference biologic. Cost savings can be substantial, though formulary placement and availability vary.
• Adjust dose or formulation. Sometimes switching from an extended-release to immediate-release version, or splitting higher-dose tablets, can bring the medication back within coverage rules (always confirm with your prescriber and pharmacist before splitting pills).
• Request a temporary or partial fill. A 7 to 14 day supply or half the usual quantity can bridge you while appeals proceed or while you trial an alternative, reducing the up-front cost and avoiding a large waste if the new drug doesn’t work.
• Use in-office administration when applicable. Some injectable or infused medications can be given at a clinic or hospital and billed under your medical benefit instead of your pharmacy benefit, potentially restoring coverage or reducing cost-sharing.

Financial Assistance Programs for Non-Covered Medications

Manufacturer patient-assistance programs and copay cards are often the most effective way to slash out-of-pocket costs for brand-name and specialty drugs, sometimes reducing your cost to zero. Copay assistance cards (also called copay coupons or savings cards) are available for many branded medications and can cut your monthly cost from hundreds or thousands of dollars down to $0 to $50 per fill. Typical savings range from $100 to more than $2,000 per month depending on the drug and the coupon’s annual cap, which is often $2,000 to $15,000 per calendar year. You present the card at the pharmacy counter just like an insurance card, and the manufacturer covers part or all of your copay or coinsurance. These cards are generally available only to people with commercial (non-government) insurance, and most prohibit use with Medicare, Medicaid, or other government programs.

Patient assistance programs (PAPs) are manufacturer-run programs that provide free or deeply discounted medications to people who meet income and insurance criteria. Eligibility thresholds vary by program but often target households earning roughly 200 to 400 percent of the federal poverty level (for 2024, that’s approximately $30,000 to $60,000 annual income for an individual, or $62,000 to $124,000 for a family of four, though exact numbers and requirements differ by manufacturer). Application processing typically takes two to eight weeks, and you’ll need to supply proof of income (tax returns or recent pay stubs), a copy of your prescription, a letter from your prescriber, and documentation of your insurance denial. Once approved, the manufacturer ships the medication to you or your prescriber’s office at no cost or for a very low program fee.

Independent nonprofit foundations and disease-specific charities offer grants and copay assistance for people with certain conditions, especially rare diseases, cancer, and chronic illnesses. Grant amounts commonly range from $250 to $5,000 per year depending on the program’s funding and your financial need, and application timelines are similar to manufacturer PAPs, expect two to eight weeks for review and approval. Pharmacy discount cards and price-comparison services let you compare cash prices across dozens of pharmacies in your area and provide a coupon or card number that reduces the price at checkout. Savings typically range from 10 to 80 percent off the retail price, and the cards are free to use (some services charge small monthly fees or per-use fees, usually $0 to $5). These tools are especially useful for generics and lower-cost brand drugs where the discounted cash price can be cheaper than your insurance copay or coinsurance.

Typical eligibility and application requirements for financial assistance:

• Proof of income: Recent tax return, W-2, or several months of pay stubs.
• Prescription and diagnosis: Current prescription from your prescriber and documentation of your medical condition.
• Insurance denial letter: Some programs require proof that your insurance denied coverage or that you’re facing unaffordable out-of-pocket costs.
• Citizenship or residency status: Most programs require U.S. citizenship or legal residency. A few are open to patients regardless of status.
• Lack of other coverage: Many manufacturer PAPs require that you have no other prescription coverage, or that your plan specifically excludes the medication in question. Copay cards generally require you to have some form of commercial insurance but not government coverage.

Pharmacy and Supply Strategies When Coverage Stops

Changing where and how you fill your prescription can cut costs significantly even when the drug itself is non-covered. Mail-order and specialty pharmacies often offer lower per-month pricing, sometimes 5 to 30 percent less, than retail pharmacies because their volume and automation reduce overhead, and many insurers waive or reduce copays for 90-day supplies ordered through their preferred mail-order partners. If you’re paying cash, a 90-day supply almost always costs less per month than filling three separate 30-day prescriptions, and warehouse clubs, online pharmacies, and independent compounding pharmacies may quote prices well below the big chains for the same medication.

Some states have emergency-fill laws that require insurers or pharmacies to provide a short-term supply, typically 7 to 30 days, when an abrupt loss of coverage would endanger your health. Transitional fill provisions in some plans also kick in automatically when you switch insurance or when the formulary changes mid-year, giving you a temporary supply while you and your prescriber work through prior authorization or appeals. Ask your pharmacist whether your state or plan offers these protections, and request them by name if the pharmacist isn’t aware.

Practical tactics to reduce costs and maintain access:

• Request 90-day fills whenever possible. Lower per-month cost and fewer trips to the pharmacy, especially useful for chronic medications you take every day.
• Compare cash prices at multiple pharmacies before filling. Call or use online tools to check prices at chain stores, independents, warehouse clubs, and mail-order pharmacies. Price differences of 30 to 70 percent for the same drug are common.
• Ask about split fills or partial quantities. Some pharmacies will dispense a smaller quantity (for example, 15 days instead of 30) at a proportionally lower cost, which can help bridge you financially while appeals or assistance applications are pending.
• Use discount cards at the pharmacy counter. Even if your insurance dropped the drug, a discount card can often bring the cash price down to a manageable level, sometimes below what your old copay was.

Special Rules for Medicare, Medicaid, and Employer Plans

Medicare Part D prescription drug plans follow federal formulary and appeals rules that differ from commercial insurance, and one of the biggest constraints is that manufacturer copay cards and coupons cannot be used by Medicare beneficiaries. Federal law prohibits it. If your Part D plan stops covering a medication, you can request a formulary exception (the Medicare term for a coverage appeal), and the plan must decide standard exception requests within 72 hours and expedited requests within 24 hours if your prescriber certifies urgency. If the plan denies your exception, you can appeal to an independent review entity, and the timelines and procedures are set by the Centers for Medicare & Medicaid Services (CMS). Part D plans are also required to provide transition fills, a temporary 30-day supply at in-network cost-sharing, when you first join the plan or when the formulary changes, giving you time to work with your prescriber on alternatives or exceptions.

Medicaid coverage varies by state, and formulary decisions are made by each state’s Medicaid agency, not a private insurer. If a drug becomes non-covered, you may be eligible for an emergency supply through your state’s Medicaid emergency refill policies, or your prescriber can request prior authorization or a medical exception. Manufacturer coupons generally cannot be used with Medicaid, similar to Medicare, but many states offer supplemental assistance programs or link patients to PAPs and nonprofit grants. State Medicaid agencies also sometimes cover drugs that federal Medicaid does not, or provide limited quantities while exceptions are processed.

Employer-sponsored group health plans update their formularies annually and sometimes mid-year, and most plans allow you to continue coverage under COBRA if you lose your job or your hours are reduced, preserving your prescription access for up to 18 or 36 months (though you pay the full premium plus a small administrative fee). Employer plans governed by ERISA have specific appeal rights, and if your plan is self-insured (meaning your employer directly pays claims rather than buying a fully insured product), your employer is the final decision-maker on appeals, not the insurance company whose logo is on your card. That distinction matters because ERISA appeal procedures and external review availability differ from state-regulated individual and small-group plans.

Documentation and Communication Needed to Restore Coverage

Appeals and exceptions succeed or fail based on the quality and completeness of the documentation your prescriber submits, not on emotional arguments or general claims that the drug “works better.” The insurer’s reviewers need to see objective clinical evidence that the non-covered medication is medically necessary, that you’ve already tried and failed formulary alternatives, and that going without it or switching to a covered drug would cause harm or significantly worse outcomes.

Start with the denial letter itself. Copy it and keep the original in a safe place, because it states the exact reason coverage was denied, the appeal deadline, and the documentation the insurer requires to reconsider. Your prescriber should provide a letter of medical necessity that includes your diagnosis (with ICD-10 codes if possible), a detailed explanation of why this specific drug is required, a list of other medications you’ve tried with dates and doses, documented outcomes or side effects from those prior therapies, objective clinical markers (lab results, imaging, symptom scores, functional assessments), and a clear statement of the expected risks if you’re forced to switch or go without. Attach recent clinic notes, hospital records if you’ve had complications, pharmacy invoices showing the cash price you’re facing, and any previous prior-authorization approvals that show the insurer has covered this drug for you in the past.

Documentation checklist for appeals and exception requests:

• The denial or coverage-change notice with effective date and stated reason.
• Current prescription including drug name, strength, dosage form, quantity, and prescriber information.
• Prescriber’s letter of medical necessity with diagnosis codes, treatment history, prior therapies tried, and clinical rationale for this specific medication.
• Recent medical records (chart notes from the past 3 to 12 months, lab results, diagnostic reports).
• Pharmacy invoices or price quotes showing the out-of-pocket cost you’re facing.
• Prior authorization history if the drug was previously approved and coverage has now lapsed or been revoked.
• Dates and notes from all phone calls with the insurer, pharmacy, and prescriber’s office (include representative names and reference numbers).

Keep copies of everything you submit, preferably sent via certified mail, tracked mail, or secure electronic portal with confirmation, and follow up within three to five business days to confirm the insurer received your appeal and assigned it a case number.

When to Escalate: Regulators, Advocates, and Legal Options

If your internal appeals are denied, the insurer misses deadlines, or you believe the denial violates your plan’s rules or state insurance law, you can escalate to your state insurance department or commissioner. State regulators have complaint and investigation processes, and in many cases they can pressure insurers to expedite reviews, correct procedural errors, or reconsider denials when the plan didn’t follow its own policies. External review processes are legally required for most non-grandfathered health plans under the Affordable Care Act, and the external reviewer’s decision is binding on the insurer, giving you a genuine second opinion from an independent medical expert.

For employer-sponsored plans governed by ERISA, the escalation path is different. ERISA requires that plans provide a “full and fair review” of denied claims, and if you exhaust the plan’s internal appeals and still believe the denial was wrong, you can file a lawsuit in federal court under ERISA Section 502(a). You generally must exhaust internal appeals before filing suit, and ERISA cases are decided by judges (not juries) based on the administrative record compiled during the appeal process, so thorough documentation at every step is critical. State insurance departments typically have no jurisdiction over self-insured ERISA plans, but the U.S. Department of Labor’s Employee Benefits Security Administration (EBSA) can investigate ERISA violations and may assist with unresolved disputes.

Consider escalating when:

• The insurer missed its own decision deadlines (for example, no response within 30 days on a standard appeal or 72 hours on an expedited appeal).
• Required documentation was ignored or lost and the insurer denied the appeal without reviewing the evidence your prescriber submitted.
• The denial contradicts clear medical evidence or the plan’s own coverage criteria, suggesting a procedural or substantive error.
• You’ve exhausted all internal appeals and external review is legally available but the insurer is blocking access or providing incorrect information about how to request it.

State insurance regulators, nonprofit patient-advocacy organizations, and legal-aid clinics can guide you through these escalation steps if the process feels overwhelming or the insurer’s responses are confusing or contradictory.

Final Words

Act fast: verify the denial, call your doctor and insurer, and ask for a bridge supply or an expedited appeal.

This post showed what to do in the first 24–72 hours, why coverage changes happen, how costs can jump, appeal and exception steps, cheaper drug options, financial help, pharmacy tricks, special-plan rules, and the paperwork you’ll need.

If you’re still asking what happens when insurance stops covering a medication, use the checklist above, get answers in writing, and push for an interim supply. You can usually find a workable option.

FAQ

Q: What to do when insurance stops covering medication?

A: When insurance stops covering a medication, act fast: verify the denial reason and effective date, call your insurer and prescriber, request samples or an expedited appeal, compare cash prices, and apply for assistance programs.

Q: Is autoimmune disease covered by insurance?

A: Autoimmune disease coverage depends on your plan; many insurers cover diagnosis and standard treatments, but biologics, off-label uses, and therapies often need prior authorization, step therapy, or proof of medical necessity—check your formulary and limits.

Q: Why doesn’t my insurance cover metformin?

A: Insurance may not cover metformin because your plan excludes a specific formulation (ER), places it on a higher tier, requires prior authorization for the indication, or you’re using it off-label—call the insurer, ask the pharmacy, and request an exception.

Q: Is osteoporosis covered by insurance?

A: Osteoporosis is usually covered for bone density tests and many treatments, but expensive drugs or specialty biologics often need prior authorization or step therapy and can carry high out-of-pocket costs—check formulary placement and appeal options.

Carrie Hill

Check out these blog posts also:

How to Evaluate Insurance Mid-Year Policy Changes That Impact Your Coverage Insurance Renewal vs New Policy: Key Differences and Which Saves Money What to Check Before Renewing Insurance After Rate Increase Do I Have to Accept Insurance Policy Changes: Your Rights and Options